Sanofi will transfer ownership of the €11.4bn Merial animal health business to Boehringer in return for the latter’s consumer healthcare (CHC) business, valued at €6.7bn and €4.7bn of
Vertex Pharmaceuticals and Bayer Global Investments led the earlier Series B investment. The second, oversubscribed closing of the Series B financing, includes various new institutional investors and specialized
The US Food and Drug Administration approved the product, branded as Cinqair in the US, in March. Cinqaero is a humanized monoclonal antibody that binds to interleukin 5
The transaction terms provided each outstanding share of Anacor to be converted into the right to get $99.25 net in cash without any interest but subject to required
It also entered into a settlement and license agreement with AstraZeneca, pursuant to which AstraZeneca granted a license to Teva to manufacture and commercialize the generic version of
Napabucasin is an orally administered cancer stemness inhibitor designed to inhibit cancer stemness pathways by targeting STAT3, and is currently being investigated in a global Phase III clinical
The US authorities have recommended against its use saying that the vaccine showed ‘poor or relatively lower effectiveness’ of LAIV from 2013 through 2016. CDS said in a
The House voted 239-171 to pass the bill. The deal matches the $1.1bn figure adopted by the Senate last month to combat the virus. Republican House Speaker Paul
The RAC also issued recommendations on several design elements of the research and clinical development program. DTX301 is an adeno-associated virus (AAV) gene therapy product being developed to
It gives Anavex a seven year window of commercial exclusivity in the US in the area of infantile spasms, prioritized consultation by the FDA on clinical studies and
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.